Market Place
Sourcing Support
Vasa Therapeutics Presents at 36th Oppenheimer Life Sciences Conf
12 Feb 2026 //
PR NEWSWIRE
FDA Grants Vasa Fast Track for VS-041 in HFpEF
18 Nov 2025 //
PR NEWSWIRE
Vasa Therapeutics Gains FDA Clearance For VS-041 Clinical Trial
14 Oct 2025 //
INDPHARMAPOST
Vasa Therapeutics Advances Small Molecule VS-041 For HFpEF
13 Oct 2025 //
PR NEWSWIRE
Vasa Completes First-in-Human Study for Heart Failure Drug
04 Jun 2025 //
PR NEWSWIRE
Quotient And Vasa Begin Human Trials Of VS-041 For Novel Heart Failure Therapy
11 Sep 2024 //
PRESS RELEASE
Vasa Therapeutics’ Lead Drug Candidate Enters Clinical Trials
10 Sep 2024 //
CONTRACT PHARMA
Vasa Therapeutics Announces Closing of Seed Financing
03 Jan 2024 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.